Jorge Galino Selected Research

Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)

1/2022	Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model.
8/2013	Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
12/2012	Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
3/2012	Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
10/2011	Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
7/2011	Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.
6/2008	Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge Galino Research Topics

Disease

7	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022 - 06/2008
2	Pain (Aches) 10/2019 - 01/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2016
2	Demyelinating Diseases (Demyelinating Disease) 04/2017 - 06/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2012 - 06/2008
1	Contusions 01/2019
1	Autism Spectrum Disorder 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 04/2017
1	Wallerian Degeneration 07/2013
1	Inflammation (Inflammations) 03/2012
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 06/2008

Drug/Important Bio-Agent (IBA)

5	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 06/2008
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2011
3	Neuregulin-1 (Neuregulin 1)IBA 01/2019 - 07/2013
3	AntioxidantsIBA 12/2012 - 07/2011
2	Amyloid (Amyloid Fibrils)IBA 10/2019 - 04/2017
2	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 08/2013 - 12/2012
1	Substance PIBA 10/2019
1	Neprilysin (Neutral Endopeptidase)IBA 10/2019
1	MMEIBA 10/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	anti-CASPR2 autoantibodyIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Complement System Proteins (Complement)IBA 04/2017
1	Immunoglobulin M (IgM)IBA 04/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Pioglitazone (Actos)FDA Link 08/2013
1	Mitochondrial Permeability Transition PoreIBA 12/2012
1	Cyclophilins (Cyclophilin)IBA 12/2012
1	EnzymesIBA 10/2011
1	Pyruvate KinaseIBA 10/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2011

Therapy/Procedure

1	Nerve Crush 07/2013
1	Therapeutics 03/2012